Elevated apolipoprotein B predicts poor postsurgery prognosis in patients with hepatocellular carcinoma

AIMS: To date, curative resection remains to be the most optimal therapeutic choice of hepatocellular carcinoma (HCC), though the overall survival (OS) remains extremely unsatisfactory. To better manage the HCC patients, we evaluated the prognosis predicting values of apolipoprotein B (ApoB) and low...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Yan, Xiaotong, Yao, Mingjie, Wen, Xiajie, Zhu, Yiwei, Zhao, Erjiang, Qian, Xiangjun, Chen, Xiangmei, Lu, Weiquan, Lv, Quanjun, Zhang, Ling, Lu, Fengmin
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6420103/
https://ncbi.nlm.nih.gov/pubmed/30881047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S192631
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados